行情

CDMO

CDMO

Avid Bioservices
NASDAQ

实时行情|Nasdaq Last Sale

5.83
+0.15
+2.64%
盘后: 5.83 0 0.00% 16:00 09/17 EDT
开盘
5.63
昨收
5.68
最高
5.84
最低
5.58
成交量
22.67万
成交额
--
52周最高
7.25
52周最低
3.370
市值
3.28亿
市盈率(TTM)
-28.9330
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CDMO 新闻

  • 联储530亿美元回购注入流动性 为金融危机来规模最大
  • 新浪财经.25分钟前
  • 反垄断执法过于宽容?美国会盘问司法部、FTC高层官员
  • 新浪美股.28分钟前
  • 沙特:石油产量9月底完全恢复 沙特阿美IPO正常推进
  • 新浪美股.1小时前
  • 调查:Z世代购物习惯或推动实体店复兴
  • 新浪美股.2小时前

更多

所属板块

制药
+0.60%
制药与医学研究
+0.42%

热门股票

名称
价格
涨跌幅

CDMO 简况

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides a variety of process development activities, including cell line development and optimization.
展开

Webull提供Avid Bioservices Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。